Literature DB >> 8149236

Increased levels of the excitotoxin quinolinic acid in spinal cord following contusion injury.

A R Blight1, K Saito, M P Heyes.   

Abstract

Products of inflammatory phagocytes are potential contributors to secondary pathology following spinal cord trauma. In the present study we quantified the levels of the neurotoxin and product of activated macrophages, quinolinic acid (QUIN), in the lower thoracic spinal cord of adult guinea pigs 5 days after brief compression injury. At the injured site (T13), elevations in tissue QUIN levels (> 10-fold) accompanied proportional increases in the activity of indoleamine-2,3 dioxygenase (> 2-fold) and the concentrations of L-kynurenine (> 2.5-fold). In contrast, no significant changes occurred in two uninjured regions examined compared to controls, namely cervical spinal cord (C2) and the somatosensory cortex. Further studies of QUIN as a potential contributor to spinal cord injury are warranted.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8149236     DOI: 10.1016/0006-8993(93)91167-q

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Maternal Inflammation Results in Altered Tryptophan Metabolism in Rabbit Placenta and Fetal Brain.

Authors:  Monica Williams; Zhi Zhang; Elizabeth Nance; Julia L Drewes; Wojciech G Lesniak; Sarabdeep Singh; Diane C Chugani; Kannan Rangaramanujam; David R Graham; Sujatha Kannan
Journal:  Dev Neurosci       Date:  2017-05-11       Impact factor: 2.984

2.  The expression of nerve growth factor receptor on Schwann cells and the effect of these cells on the regeneration of axons in traumatically injured human spinal cord.

Authors:  Z H Wang; G F Walter; L Gerhard
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

3.  Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.

Authors:  M P Heyes; C L Achim; C A Wiley; E O Major; K Saito; S P Markey
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

Review 4.  Kynurenines in the mammalian brain: when physiology meets pathology.

Authors:  Robert Schwarcz; John P Bruno; Paul J Muchowski; Hui-Qiu Wu
Journal:  Nat Rev Neurosci       Date:  2012-07       Impact factor: 34.870

Review 5.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

6.  Smaller Dentate Gyrus and CA2 and CA3 Volumes Are Associated with Kynurenine Metabolites in Collegiate Football Athletes.

Authors:  Timothy B Meier; Jonathan Savitz; Rashmi Singh; T Kent Teague; Patrick S F Bellgowan
Journal:  J Neurotrauma       Date:  2016-01-13       Impact factor: 5.269

7.  Neurorestorative targets of dietary long-chain omega-3 fatty acids in neurological injury.

Authors:  Johnny D Figueroa; Marino De Leon
Journal:  Mol Neurobiol       Date:  2014-04-17       Impact factor: 5.590

8.  Species and cell types difference in tryptophan metabolism.

Authors:  Yuki Murakami; Kuniaki Saito
Journal:  Int J Tryptophan Res       Date:  2013-07-21

Review 9.  Inhibiting the kynurenine pathway in spinal cord injury: Multiple therapeutic potentials?

Authors:  Kelly R Jacobs; David B Lovejoy
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.